Clinical Trials Detalhe

Liver cirrhosis patients in Intensive Care present intra-abdominal hypertension and this is an independent risk factor for increased organ disfunction and mortality. Patients will be randomized into intermittent or continuous passive paracentesis and the clinical results of these two strategies for preventing and treating intra-abdominal hypertension will compared.

Ascites Hepatic

Cirrhosis, Liver

Hypertension, Intraabdominal

Critical Illness

Paracentesis

Inclusion Criteria: * liver cirrhosis diagnosis with ascites * ICU admission for medical reason Exclusion Criteria: * prior liver transplant * haemorrhagic ascites * extreme severity: CLIF-SOFA number of organ failures 5 or more * less than 24 hours of ICU stay * Any of the following conditions at 24 hours of ICU stay: i. Hemorrhagic shock with active uncontrolled bleeding ii. Refractory shock (MAP\<60mmHg) with multiple vasopressors iii. Predictably short ICU stay (\<72 hours) iv. Therapeutic futility determined by the medical staff